Fas ligand expressed in colon cancer is associated with suppression of activation and IL-2 production in tumor-infiltrating T-cells

Houston, A., Bennett, M. W., O’Sullivan, G. C., Shanahan, F., & O’Connell, J. (2001). Fas ligand expressed in colon cancer is associated with suppression of activation and IL-2 production in tumor-infiltrating T-cells. Gastroenterology, 120(5), A660. https://doi.org/10.1016/s0016-5085(08)83282-9